Contemporary Tools for the Diagnosis and Management of Invasive Mycoses
Data up to Jan 2025
Total Citations Per Year
Abstract
References (102)
Manual of Clinical Microbiology.
1980 • 14,937 citations
Manual of clinical microbiology
2003 • 2,635 citations
Guidelines for Treatment of Candidiasis
2004 • 1,463 citations
Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections
1997 • 862 citations
Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyondCandida albicansandAspergillus fumigatus
2004 • 691 citations
Multicenter Clinical Evaluation of the (1->3) -D-Glucan Assay as an Aid to Diagnosis of Fungal Infections in Humans
2005 • 651 citations
-D-Glucan as a Diagnostic Adjunct for Invasive Fungal Infections: Validation, Cutoff Development, and Performance in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome
2004 • 637 citations
CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species
1994 • 634 citations
Infections due to emerging and uncommon medically important fungal pathogens
2004 • 594 citations
Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States
2003 • 503 citations
Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis
2004 • 481 citations
Detection of Galactomannan Antigenemia by Enzyme Immunoassay for the Diagnosis of Invasive Aspergillosis: Variables That Affect Performance
2004 • 473 citations
Update on detection of bacteremia and fungemia
1997 • 459 citations
Antifungal Therapy Decreases Sensitivity of theAspergillus Galactomannan Enzyme Immunoassay
2005 • 457 citations
Antifungal Susceptibility Testing: Practical Aspects and Current Challenges
2001 • 451 citations
The Impact of Culture Isolation ofAspergillusSpecies: A Hospital‐Based Survey of Aspergillosis
2001 • 444 citations
Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis
1999 • 386 citations
Utilization of the internal transcribed spacer regions as molecular targets to detect and identify human fungal pathogens
2002 • 358 citations
Has Antifungal Susceptibility Testing Come of Age?
2002 • 357 citations
Contribution of (1→3)-β- <scp>d</scp> -Glucan Chromogenic Assay to Diagnosis and Therapeutic Monitoring of Invasive Aspergillosis in Neutropenic Adult Patients: a Comparison with Serial Screening for Circulating Galactomannan
2005 • 332 citations
The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis
1996 • 316 citations
Prospective Comparison of the Diagnostic Potential of Real-Time PCR, Double-Sandwich Enzyme-Linked Immunosorbent Assay for Galactomannan, and a (1→3)-β- <scp>d</scp> -Glucan Test in Weekly Screening for Invasive Aspergillosis in Patients with Hematological Disorders
2004 • 290 citations
Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing
2006 • 286 citations
AspergillusGalactomannan Enzyme Immunoassay and Quantitative PCR for Diagnosis of Invasive Aspergillosis with Bronchoalveolar Lavage Fluid
2004 • 285 citations
Current Status of Nonculture Methods for Diagnosis of Invasive Fungal Infections
2002 • 285 citations
Significance of isolation of aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study
1986 • 282 citations
Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints
2006 • 257 citations
False‐Positive Galactomannan PlateliaAspergillusTest Results for Patients Receiving Piperacillin‐Tazobactam
2004 • 247 citations
Multiechinocandin- and Multiazole-ResistantCandida parapsilosisIsolates Serially Obtained during Therapy for Prosthetic Valve Endocarditis
2005 • 243 citations
Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study
2001 • 234 citations
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi
1997 • 234 citations
Results from the ARTEMIS DISK Global AntifungalSurveillance Study: a 6.5-Year Analysis of Susceptibilitiesof Candida and Other Yeast Species to Fluconazole andVoriconazole by Standardized Disk Diffusion Testing
2005 • 226 citations
Quality Control Limits for Broth Microdilution Susceptibility Tests of Ten Antifungal Agents
2000 • 220 citations
Galactomannan detection in computerized tomography‐based broncho‐alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis
2003 • 215 citations
Plasma (1-->3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis
1995 • 210 citations
Detection of amphotericin B-resistant Candida isolates in a broth-based system
1995 • 202 citations
Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates
1995 • 200 citations
In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance
2006 • 195 citations
Activities of Fluconazole and Voriconazole against 1,586 Recent Clinical Isolates of Candida Species Determined by Broth Microdilution, Disk Diffusion, and Etest Methods: Report from The ARTEMIS Global Antifungal Susceptibility Program, 2001
2003 • 195 citations
Treatment with Piperacillin‐Tazobactam and False‐PositiveAspergillusGalactomannan Antigen Test Results for Patients with Hematological Malignancies
2004 • 191 citations
Assessment of Ribosomal Large-Subunit D1-D2, Internal Transcribed Spacer 1, and Internal Transcribed Spacer 2 Regions as Targets for Molecular Identification of Medically Important Aspergillus Species
2005 • 181 citations
Cryptococcosis in Organ Transplant Recipients: An Overview
2002 • 175 citations
Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against Candida and Aspergillus Species
2004 • 172 citations
Aspergillus Fungemia: Report of Two Cases and Review
1995 • 169 citations
In Vitro Activities of Anidulafungin against More than 2,500 Clinical Isolates of Candida spp., Including 315 Isolates Resistant to Fluconazole
2005 • 163 citations
Caspofungin Resistance inCandida albicans: Correlating Clinical Outcome with Laboratory Susceptibility Testing of Three Isogenic Isolates Serially Obtained from a Patient with Progressive Candida Esophagitis
2004 • 162 citations
Fluorescence In Situ Hybridization with Peptide Nucleic Acid Probes for Rapid Identification of Candida albicans Directly from Blood Culture Bottles
2002 • 158 citations
Use of Calcofluor White in Clinical Mycology
1984 • 156 citations
Evaluation of Possible Correlations between Antifungal Susceptibilities of Filamentous Fungi In Vitro and Antifungal Treatment Outcomes in Animal Infection Models
1998 • 152 citations
Efficacy of Galactomannan Antigen in the Platelia Aspergillus Enzyme Immunoassay for Diagnosis of Invasive Aspergillosis in Liver Transplant Recipients
2004 • 144 citations
Direct identification and recognition of yeast species from clinical material by using albicans ID and CHROMagar Candida plates
1996 • 136 citations
Caspofungin Susceptibility Testing of Isolates from Patients with Esophageal Candidiasis or Invasive Candidiasis: Relationship of MIC to Treatment Outcome
2005 • 136 citations
Multicenter Evaluation of a Candida albicans Peptide Nucleic Acid Fluorescent In Situ Hybridization Probe for Characterization of Yeast Isolates from Blood Cultures
2005 • 128 citations
Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures
2006 • 123 citations
Identification of Medically Important Molds by an Oligonucleotide Array
2005 • 121 citations
Bifidobacterium lipoteichoic acid and false ELISA reactivity in aspergillus antigen detection
2004 • 120 citations
Experience with the MicroSeq D2 Large-Subunit Ribosomal DNA Sequencing Kit for Identification of Filamentous Fungi Encountered in the Clinical Laboratory
2004 • 107 citations
Elevation of Blood (1→3)-Beta-<i>D</i>-Glucan Concentrations in Hemodialysis Patients
2001 • 105 citations
False-Positive Aspergillus Galactomannan Enzyme-Linked Immunosorbent Assay Results In Vivo during Amoxicillin-Clavulanic Acid Treatment
2004 • 102 citations
Detection of plasma (1 → 3)-β-<scp>d</scp>-glucan in patients withFusarium, Trichosporon, SaccharomycesandAcremoniumfungaemias
1997 • 102 citations
Diagnosis of histoplasmosis by antigen detection based upon experience at the histoplasmosis reference laboratory
2002 • 102 citations
False-positive result in Limulus test caused by Limulus amebocyte lysate-reactive material in immunoglobulin products
1989 • 97 citations
Activities of Micafungin against 315 Invasive Clinical Isolates of Fluconazole-Resistant Candida spp
2006 • 96 citations
E-Test Method for Testing Susceptibilities of Aspergillus spp. to the New Triazoles Voriconazole and Posaconazole and to Established Antifungal Agents: Comparison with NCCLS Broth Microdilution Method
2002 • 96 citations
Evaluation of Broth Microdilution Testing Parameters and Agar Diffusion Etest Procedure for Testing Susceptibilities of Aspergillus spp. to Caspofungin Acetate (MK-0991)
2003 • 94 citations
Comparison of Results of Voriconazole Disk Diffusion Testing for Candida Species with Results from a Central Reference Laboratory in the ARTEMIS Global Antifungal Surveillance Program
2005 • 93 citations
Evaluation of etest for determining in vitro susceptibility of yeast isolates to amphotericin B
1998 • 91 citations
Correlation between In Vitro Susceptibility Determined by E Test and Response to Therapy with Amphotericin B: Results from a Multicenter Prospective Study of Candidemia
1999 • 90 citations
Further Standardization of Broth Microdilution Methodology for In Vitro Susceptibility Testing of Caspofungin against Candida Species by Use of an International Collection of More than 3,000 Clinical Isolates
2004 • 89 citations
Multicenter Comparison of the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A2 Reference Method for Testing New Antifungal Agents against Clinical Isolates of Candida spp
2004 • 87 citations
False-positive endotoxemia derives from gauze glucan after hepatectomy for hepatocellular carcinoma with cirrhosis.
1997 • 83 citations
In Vitro Susceptibilities of Clinical Isolates of Candida Species, Cryptococcus neoformans , and Aspergillus Species to Itraconazole: Global Survey of 9,359 Isolates Tested by Clinical and Laboratory Standards Institute Broth Microdilution Methods
2005 • 83 citations
Comparative evaluation of chemiluminescent DNA probe assays and exoantigen tests for rapid identification of Blastomyces dermatitidis and Coccidioides immitis
1994 • 77 citations
Multicenter Comparative Evaluation of Six Commercial Systems and the National Committee for Clinical Laboratory Standards M27-A Broth Microdilution Method for Fluconazole Susceptibility Testing of Candida Species
2002 • 75 citations
Diagnosis of invasive fungal infections: advances in nonculture systems.
1998 • 75 citations
Experience with the MicroSeq D2 Large-Subunit Ribosomal DNA Sequencing Kit for Identification of Commonly Encountered, Clinically Important Yeast Species
2003 • 75 citations
Laboratory Methods for the Diagnosis and Confirmation of Systemic Mycoses
1992 • 74 citations
In Vitro Susceptibility Testing of Aspergillus spp.: Comparison of Etest and Reference Microdilution Methods for Determining Voriconazole and Itraconazole MICs
2003 • 74 citations
Clinical Evaluation of the Sensititre YeastOne Colorimetric Antifungal Plate for Antifungal Susceptibility Testing of the New Triazoles Voriconazole, Posaconazole, and Ravuconazole
2004 • 71 citations
Arterial Infections Due to Listeria monocytogenes: Report of Four Cases and Review of World Literature
1992 • 71 citations
LABORATORY DIAGNOSIS OF BACTEREMIA AND FUNGEMIA
2001 • 69 citations
Evaluation of Etest Method for Determining Caspofungin (MK-0991) Susceptibilities of 726 Clinical Isolates of Candida Species
2001 • 63 citations
Performance Accuracy of Antibacterial and Antifungal Susceptibility Test Methods: Report From the College of American Pathologists Microbiology Surveys Program (2001–2003)
2006 • 62 citations
Laboratory Detection of Fungemia
1994 • 62 citations
Influences of Methodological Variables on Susceptibility Testing of Caspofungin against Candida Species and Aspergillus fumigatus
2003 • 62 citations
Evaluation of the Etest Method Using Mueller-Hinton Agar with Glucose and Methylene Blue for Determining Amphotericin B MICs for 4,936 Clinical Isolates of Candida Species
2004 • 53 citations
Comparison of Results of Fluconazole Disk Diffusion Testing for Candida Species with Results from a Central Reference Laboratory in the ARTEMIS Global Antifungal Surveillance Program
2004 • 53 citations
Evaluation of Etest Method for Determining Fluconazole and Voriconazole MICs for 279 Clinical Isolates of Candida Species Infrequently Isolated from Blood
2003 • 50 citations
Comparative evaluation of a chemiluminescent DNA probe and an exoantigen test for rapid identification of Histoplasma capsulatum
1992 • 46 citations
Evaluation of BACTEC MYCO/F Lytic Medium for Recovery of Mycobacteria and Fungi from Blood
1998 • 42 citations
Mycoses in the transplanted patient
2000 • 41 citations
Molecular Microbiology
2005 • 39 citations
Evaluation of Etest Method for Determining Posaconazole MICs for 314 Clinical Isolates of Candida Species
2001 • 33 citations
CHROMagar Candida Medium for Direct Susceptibility Testing of Yeast from Blood Cultures
2005 • 32 citations
Real-time antifungal susceptibility screening aids management of invasive yeast infections in immunocompromised patients
2002 • 31 citations
Quality Control Limits for Posaconazole Disk Susceptibility Tests on Mueller-Hinton Agar with Glucose and Methylene Blue
2006 • 31 citations
Algorithms for detection and identification of fungi.
2006 • 30 citations
Utility of real-time antifungal susceptibility testing for fluconazole in the treatment of candidemia
2004 • 28 citations
Quality Control Limits for Fluconazole Disk Susceptibility Tests on Mueller-Hinton Agar with Glucose and Methylene Blue
2003 • 21 citations
Routine Use of a Commercial Test, GLABRATA RTT, for Rapid Identification of Candida glabrata in Six Laboratories
2004 • 21 citations
Early Diagnosis and Treatment of Pulmonary Opportunistic Infection by Using Polymerase Chain Reaction and .BETA.-glucan in Patients with Hematological Neoplasms.
2001 • 18 citations
Quality Control Limits for Voriconazole Disk Susceptibility Tests on Mueller-Hinton Agar with Glucose and Methylene Blue
2004 • 13 citations